{"gene":"HTR7","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1994,"finding":"5-HT7 receptor activation in rat suprachiasmatic nucleus neurons inhibits GABA-activated current (IGABA) via a cAMP-coupled signaling mechanism; the effect was blocked by ritanserin (a 5-HT7 antagonist) but not by pindolol (5-HT1A/B antagonist), and was mimicked by forskolin and 8-bromo-cAMP, with H-8 (PKA inhibitor) reducing the 5-HT effect, indicating 5-HT7 receptor couples to cAMP/PKA to modulate GABAA receptor currents.","method":"Whole-cell voltage-clamp recordings in rat SCN neurons with selective agonists, antagonists, and PKA inhibitors","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiology with pharmacological dissection, multiple orthogonal tools (agonists, antagonists, PKA inhibitor, cAMP analogs), replicating receptor-cAMP-PKA pathway","pmids":["7965836"],"is_preprint":false},{"year":1997,"finding":"5-HT7 receptors mediate serotonin's suppression of light-evoked (photic) responses in hamster suprachiasmatic nucleus neurons; effects of 5-HT, 8-OH-DPAT, and 5-CT were blocked by 5-HT7-active antagonists (ritanserin, clozapine) but not by selective 5-HT1A antagonists (WAY100635, p-MPPI) or the 5-HT1A/B/D antagonist cyanopindolol, establishing the 5-HT7 subtype as the principal mediator of serotonergic modulation of SCN photic responses.","method":"Single-unit electrophysiology in hamster SCN slices with pharmacological dissection using selective 5-HT7 and 5-HT1A antagonists; regional specificity confirmed in hippocampus and cerebellum controls","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiology with rigorous pharmacological dissection across multiple brain regions, clear pharmacological specificity","pmids":["9175892"],"is_preprint":false},{"year":1997,"finding":"Two human 5-HT7 splice variants (h5-HT7a and h5-HT7b), differing in their intracellular C-terminal tail length, are both functionally expressed and positively coupled to adenylyl cyclase in NIH-3T3 cells; both variants are expressed in roughly equal amounts in various human brain regions.","method":"Molecular cloning, expression in NIH-3T3 cells, cAMP functional assay, Southern blot, and brain region mRNA analysis","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct molecular cloning, heterologous expression, and functional (cAMP) assay confirming Gs coupling; replicated across splice variants","pmids":["9303561"],"is_preprint":false},{"year":1997,"finding":"A truncated human 5-HT7 splice variant (h5-HT7b) was cloned, stably expressed in HEK293 cells, and shown to exhibit the same pharmacological profile and positive coupling to adenylyl cyclase as the long form (h5-HT7a); the receptor mRNA is found in brain, small intestine, and aorta.","method":"cDNA library cloning, stable HEK293 expression, radioligand binding ([3H]-5-CT), cAMP stimulation assay, RT-PCR","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in heterologous cells, binding and functional assays; replicated across both splice variants","pmids":["9298538"],"is_preprint":false},{"year":2002,"finding":"All three human 5-HT7 splice variants (h5-HT7a, h5-HT7b, h5-HT7d) display constitutive adenylyl cyclase activation; certain antagonists (e.g., methiothepin) act as inverse agonists by reducing basal cAMP, an effect blocked by the neutral antagonist mesulergine, demonstrating receptor-level constitutive activity independent of agonist stimulation.","method":"Stably and transiently transfected HEK293 cell membranes, adenylyl cyclase assay, inverse agonism profiling with 8 antagonists","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal pharmacological and biochemical assays on reconstituted receptor in defined cell system; all three variants tested","pmids":["11906971"],"is_preprint":false},{"year":2003,"finding":"5-HT-induced hypothermia is mediated by the 5-HT7 receptor: both 5-HT and 5-CT failed to induce hypothermia in 5-HT7 knockout mice at physiological doses. Oleamide, a lipid that allosterically interacts with 5-HT7, induced hypothermia equally in knockout and wild-type mice, indicating an independent/additional mechanism, and showed additive or greater-than-additive effects with 5-HT.","method":"5-HT7 receptor knockout mice, body temperature measurement, pharmacological challenge with 5-HT, 5-CT, and oleamide","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with rigorous pharmacological dissection, multiple agonists tested, mechanistic insight into allosteric modulation by oleamide","pmids":["12529502"],"is_preprint":false},{"year":2004,"finding":"Both 5-HT7 and 5-HT1A receptors contribute to 8-OH-DPAT-induced hypothermia; at lower doses, hypothermia in wild-type mice is fully blocked by the selective 5-HT7 antagonist SB-269970 and is absent in 5-HT7 knockout mice, demonstrating that 5-HT7 is the dominant receptor at physiologically relevant concentrations while 5-HT1A mediates effects at higher doses.","method":"5-HT7 knockout and wild-type mice, selective antagonists (SB-269970, WAY-100135), body temperature measurement across dose ranges","journal":"European journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — combined genetic knockout and selective pharmacology, dose-response analysis, replicated across rodent species","pmids":["15033384"],"is_preprint":false},{"year":2005,"finding":"5-HT7 receptor knockout mice display antidepressant-like behavior (decreased immobility in forced swim and tail suspension tests) and reduced REM sleep, mirroring effects of the selective 5-HT7 antagonist SB-269970; citalopram (SSRI) decreased immobility in both 5-HT7+/+ and 5-HT7−/− mice, indicating it utilizes an independent mechanism.","method":"5-HT7 knockout mice, forced swim test, tail suspension test, sleep EEG recording, selective antagonist SB-269970, SSRI citalopram","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout combined with pharmacological validation, multiple behavioral models and sleep measures, independent replication of antidepressant-like phenotype","pmids":["16018977"],"is_preprint":false},{"year":2005,"finding":"5-HT7 receptors are localized presynaptically (on peptidergic primary afferent terminals and intrinsic axons, ~60% of labeling in lamina I) and postsynaptically (on peptidergic cell bodies and dendrites) in the rat dorsal spinal cord, and also in astrocytes (~17–20%), providing morphological basis for 5-HT7 involvement in nociceptive processing.","method":"Immunocytochemistry and electron microscopy on rat lumbar spinal cord","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — detailed subcellular localization by electron microscopy, single-lab study with quantitative analysis, no direct functional validation in same paper","pmids":["16082681"],"is_preprint":false},{"year":2005,"finding":"5-HT7 receptors mediate inhibition of peristalsis in the guinea-pig ileum: the selective antagonist SB-269970-A concentration-dependently antagonized the 5-HT- or 5-CT-induced increase in the threshold required to trigger peristalsis and could restore blocked peristalsis.","method":"Isolated guinea-pig ileum peristalsis assay, selective 5-HT7 antagonist SB-269970-A and methiothepin, 5-HT2/3/4 receptor blockade as background","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional organ-bath pharmacology with selective antagonist, single lab","pmids":["12711620"],"is_preprint":false},{"year":2005,"finding":"5-HT7 receptors expressed on myenteric neurons (including descending/inhibitory neurons containing nNOS/VIP and after-hyperpolarizing neurons) modulate circular muscle accommodation during peristalsis in the guinea-pig ileum; SB-269970 increased threshold pressure and reduced accommodation.","method":"Immunohistochemistry, confocal microscopy, isolated ileal peristalsis assay with SB-269970","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combined localization (confocal) and functional pharmacology in same organ, single lab","pmids":["16285955"],"is_preprint":false},{"year":2008,"finding":"5-HT7 receptor agonists (AS-19, E-55888) dose-dependently reduced capsaicin-induced mechanical hypersensitivity in mice; the effect was blocked by 5-HT7 antagonists but not by 5-HT1A antagonist WAY-100635. The order of antinociceptive efficacy matched their in vitro efficacy to stimulate cAMP in HEK-293F cells expressing the human 5-HT7 receptor, establishing a direct correlation between 5-HT7 Gs/cAMP intrinsic efficacy and antinociception.","method":"In vitro cAMP assay in HEK-293F cells (human 5-HT7 receptor), radioligand binding, in vivo capsaicin mechanical hypersensitivity model with selective agonists and antagonists","journal":"Pain","confidence":"High","confidence_rationale":"Tier 1 / Moderate — parallel in vitro functional assay (cAMP, binding) and in vivo pharmacology with multiple selective compounds, mechanistic correlation between cAMP efficacy and behavior","pmids":["19118950"],"is_preprint":false},{"year":2009,"finding":"5-HT7 receptor-deficient mice show selective impairment in allocentric (hippocampus-dependent) spatial memory but intact egocentric (striatum-dependent) memory; identical hippocampal neurogenesis (BrdU) in knockout and wild-type mice indicates the spatial memory role is independent of adult neurogenesis.","method":"5-HT7 knockout mice, novel location/object test, Barnes maze, BrdU immunohistochemistry; pharmacological confirmation with SB-269970 in C57BL/6J mice","journal":"Behavioural brain research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with pharmacological replication, multiple behavioral paradigms, neurogenesis ruled out as mechanism","pmids":["19447277"],"is_preprint":false},{"year":2011,"finding":"Spinal 5-HT7 receptor activation by intrathecal AS-19 elicits long-lasting phrenic motor facilitation (PMF >120 min) via a signaling pathway requiring new TrkB synthesis and activity (blocked by k252a and TrkB siRNA) and downstream PI3K/AKT activation, but not BDNF synthesis — a mechanism distinct from 5-HT2 receptor-dependent PMF.","method":"Intrathecal agonist/antagonist injections in anesthetized rats, TrkB siRNA, k252a (TrkB inhibitor), PI3K and MEK pathway inhibitors, phrenic nerve electrophysiology","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal interventions (pharmacology, siRNA, kinase inhibitors) in the same system converging on TrkB-PI3K pathway","pmids":["21242254"],"is_preprint":false},{"year":2011,"finding":"5-HT7 receptor activation in the hippocampal CA1 area increases the frequency (but not amplitude) of spontaneous IPSCs in pyramidal neurons by two mechanisms: (1) enhancement of excitatory glutamatergic input to GABAergic interneurons (likely via presynaptic 5-HT7 receptors, partially TTX- and kynurenic acid-sensitive) and (2) direct excitation of interneurons increasing GABA release (TTX-resistant component).","method":"Whole-cell patch-clamp recordings in rat hippocampal slices, 5-CT + WAY-100635 (to isolate 5-HT7), TTX, kynurenic acid, selective 5-HT7 antagonist","journal":"Journal of physiology and pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiology with pharmacological dissection, TTX/kynurenic acid experiments separating two distinct mechanisms","pmids":["22204801"],"is_preprint":false},{"year":2012,"finding":"5-HT1A and 5-HT7 receptors form heterodimers (and respective homodimers) both in vitro and in vivo; 5-HT7-5-HT7 homodimers have the highest affinity for complex formation, followed by 5-HT7-5-HT1A heterodimers, then 5-HT1A-5-HT1A homodimers. Heterodimerization decreases 5-HT1A-mediated Gi protein activation and GIRK channel activity without affecting 5-HT7 signaling, promotes 5-HT1A receptor internalization, enhances 5-HT1A-mediated MAPK activation, and is physiologically relevant in hippocampal neurons.","method":"FRET-based assays (homo/heterodimer affinity), Gi functional assay, GIRK channel recordings in heterologous system and hippocampal neurons, internalization assay, MAPK assay; 5-HT7 expression tracked developmentally","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (FRET, electrophysiology, functional signaling, internalization), validated in native neurons, rigorous mechanistic dissection","pmids":["22357950"],"is_preprint":false},{"year":2013,"finding":"HTR7 (5-HT7 receptor) mediates serotonin-induced macrophage polarization toward M2 (anti-inflammatory) state: 5-HT7 alone mediates inhibition of LPS-induced proinflammatory cytokine release, and together with 5-HT2B mediates upregulation of M2-associated genes; blockade of 5-HT7 (and 5-HT2B) during monocyte-to-macrophage differentiation preferentially reduced M2 polarization markers.","method":"Human macrophage culture, selective receptor antagonists (5-HT7 and 5-HT2B), cytokine ELISA, gene expression analysis, in vitro polarization assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with selective antagonists in primary human cells, two orthogonal readouts (cytokines and gene expression), single lab","pmids":["23355731"],"is_preprint":false},{"year":2013,"finding":"5-HT7R activation in hepatocytes stimulates cAMP/PKA activity, phospho-CREB, and pERK/pAKT signaling, leading to IGF-1 synthesis and secretion; all effects were reversed by the 5-HT7 antagonist SB269970, demonstrating a functional 5-HT7 receptor coupled to cAMP/PKA and CREB/AKT in hepatocytes.","method":"Isolated rat hepatocytes, PCR/sequencing/Western blot for receptor expression, ELISA and cAMP/PKA assay, phospho-protein Western blots, antagonist reversal","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical assays in primary hepatocytes, antagonist reversal as specificity control, single lab","pmids":["23578138"],"is_preprint":false},{"year":2013,"finding":"Spinal 5-HT7 receptor activation constrains acute intermittent hypoxia (AIH)-induced phrenic long-term facilitation (pLTF) via PKA: intrathecal 5-HT7 antagonist (SB-269970) or PKA inhibitor (KT-5720) both enhanced pLTF, while PKA activation (8-br-cAMP) blunted pLTF, identifying a Gs/PKA signaling branch that negatively regulates 5-HT2-dependent spinal motor plasticity.","method":"Intrathecal injections in anesthetized rats, selective 5-HT7 antagonist, PKA inhibitor and activator, phrenic nerve electrophysiology","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — pharmacological and biochemical dissection with selective agents for 5-HT7, PKA inhibitor and activator converging on same result; mechanistic contrast with prior facilitation paper","pmids":["23850591"],"is_preprint":false},{"year":2014,"finding":"5-HT7 receptor is critically involved in acute and chronic intestinal inflammation: expressed on CD11c/CD86-positive myeloid cells in the large intestine, 5-HT7R expression increased after colitis induction; genetic ablation or pharmacological blockade worsened colitis severity, while receptor stimulation was anti-inflammatory; bone marrow chimera experiments demonstrated that 5-HT7R on hematopoietic (CD11c+) cells mediates this effect.","method":"5-HT7R knockout mice, DSS acute/chronic colitis model, pharmacological agonist/antagonist treatment, bone marrow chimera, MRI, histology, immunophenotyping","journal":"Inflammatory bowel diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout, bone marrow chimera (cell-type specificity), pharmacological modulation, and multiple disease readouts in same study","pmids":["25072499"],"is_preprint":false},{"year":2014,"finding":"S100B, a Ca2+-binding protein, physically interacts with the 5-HT7 receptor and negatively regulates 5-HT7-mediated cAMP accumulation in transfected HeLa cells and mouse cortical astrocytes; S100B overexpression causes brain-region-specific dysregulation of cAMP and depressive-like behavior in female mice, reversible by 5-HT7 blockade.","method":"Co-immunoprecipitation/interaction assay, cAMP accumulation in transfected HeLa cells and primary astrocytes, S100B transgenic mice, forced swim test, pharmacological blockade with SB269970","journal":"European neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding interaction plus functional cAMP assay in two cell systems, transgenic mouse behavioral validation, single lab","pmids":["26499172"],"is_preprint":false},{"year":2015,"finding":"5-HT7R activation promotes formation of dendritic spines and synaptogenesis in postnatal cortical and striatal neurons via CDK5 and small GTPase Cdc42 as downstream effectors; neurons from 5-HT7R knockout mice or pharmacologically blocked receptors have decreased spine numbers, indicating constitutive 5-HT7R activity contributes to spinogenesis.","method":"Primary cortical/striatal neuron cultures, selective agonist LP-211, 5-HT7R knockout neurons, antagonist treatment, confocal imaging of dendritic spines, CDK5 and Cdc42 inhibitors","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout, pharmacological agonist/antagonist, and downstream effector inhibitors converging on spine density phenotype; multiple neuronal populations","pmids":["28122114"],"is_preprint":false},{"year":2015,"finding":"5-HT7R activation stimulates neurite/axonal elongation through multiple signaling pathways: mTOR, Rho GTPase Cdc42, CDK5, and ERK, which converge on actin cytoskeleton reorganization; LP-211 treatment altered expression profile of cofilin (actin-binding protein), and axonal elongation was confirmed using microfluidic chambers separating axons from soma/dendrites.","method":"Primary cortical/hippocampal/striatal neuron cultures, selective agonist LP-211, pharmacological inhibitors of mTOR/Cdc42/CDK5/ERK, 2D-Western blot for cofilin, microfluidic chamber assay for axonal elongation, actin polymerization drugs","journal":"Frontiers in behavioral neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple signaling pathway dissections with orthogonal inhibitors, actin biochemistry, microfluidic spatial separation of axonal compartment, multiple neuronal cell types","pmids":["25814944"],"is_preprint":false},{"year":2015,"finding":"HTR7 is a key mediator of serotonergic acute and chronic itch: HTR7 activation promotes opening of the ion channel TRPA1, triggering itch behaviors; acute itch from serotonin or SSRI required both HTR7 and TRPA1; in a mouse model of atopic dermatitis, mice lacking HTR7 or TRPA1 showed reduced scratching and skin lesion severity.","method":"Genetic screen across mouse strains for itch co-regulated transcripts, HTR7 and TRPA1 knockout mice, serotonin/SSRI-induced itch behavioral assay, atopic dermatitis model","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockouts of both HTR7 and TRPA1, multiple itch models (acute and chronic), epistatic interaction established between HTR7 and TRPA1","pmids":["26074006"],"is_preprint":false},{"year":2015,"finding":"Spinal 5-HT7 receptor-induced phrenic motor facilitation is mediated by EPAC (exchange protein activated by cAMP), not PKA: EPAC inhibitor (ESI-05) abolished 5-HT7 agonist-induced PMF, while PKA inhibitor (KT-5720) did not; direct EPAC activation was sufficient to elicit PMF; mTORC1 is required downstream, as intrathecal rapamycin abolished both 5-HT7- and EPAC-induced PMF, establishing a 5-HT7 → cAMP → EPAC → mTORC1 pathway for spinal motor plasticity.","method":"Intrathecal agonist injections in anesthetized rats, selective EPAC inhibitor (ESI-05), PKA inhibitor (KT-5720), EPAC activator (8-pCPT-2'-Me-cAMP), mTORC1 inhibitor (rapamycin), phrenic nerve electrophysiology","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal pharmacological interventions (EPAC inhibitor, PKA inhibitor, direct EPAC activator, mTORC1 inhibitor) establishing linear pathway; direct sufficiency test included","pmids":["26269554"],"is_preprint":false},{"year":2015,"finding":"5-HT7R activation induces cerebellar long-term depression (LTD) at the parallel fiber-Purkinje cell synapse via a postsynaptic PKC-MAPK signaling pathway; a 5-HT7R antagonist abolished standard parallel fiber-induced LTD, and a 5-HT7R agonist impaired LTP induced by 1 Hz stimulation, demonstrating 5-HT7R as a bidirectional regulator of cerebellar synaptic plasticity.","method":"Patch-clamp recordings in cerebellar slices of adult mice, selective 5-HT7R agonist LP-211, antagonist, PKC and MAPK inhibitors","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiology with pathway inhibitors (PKC, MAPK) and selective pharmacology establishing postsynaptic mechanism; both LTD and LTP arms tested","pmids":["26482421"],"is_preprint":false},{"year":2020,"finding":"5-HT7R physically interacts with CDK5, and constitutive (G-protein-independent) 5-HT7R activity is required for Tau hyperphosphorylation and formation of highly bundled Tau structures (HBTS) via CDK5; 5-HT7R-mediated CDK5 activation induces neuronal death, reduced LTP, and impaired memory in a Tau[R406W] mouse model; blockade of constitutive 5-HT7R activity prevented Tau hyperphosphorylation and neurotoxicity, and 5-HT7R knockdown in prefrontal cortex abrogated LTP deficits and memory impairments.","method":"Co-immunoprecipitation (5-HT7R–CDK5 interaction), Tau[R406W] overexpression mouse model, pharmacological blockade of constitutive 5-HT7R activity, 5-HT7R shRNA knockdown in prefrontal cortex, LTP recording, behavioral memory tests, CDK5 activity assays","journal":"Progress in neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein interaction (Co-IP), genetic knockdown, pharmacological blockade, electrophysiology (LTP), and behavior in same study; G-protein-independent mechanism established","pmids":["32841723"],"is_preprint":false},{"year":2022,"finding":"5-HT7R activation in the hippocampal CA1 region induces depressive-like behavior in an MMP-9-dependent manner: acute LP-211 (5-HT7R agonist) administration induced depressive-like behavior in mice, accompanied by dendritic spine elongation and decreased spine density; pharmacological modulation of 5-HT7R downstream effectors during chronic unpredictable stress similarly activated the 5-HT7R/MMP-9 pathway in CA1; post mortem human brain samples from depressed individuals revealed increased MMP-9 enzymatic activity in the hippocampus.","method":"5-HT7R agonist LP-211 in mice, MMP-9 inhibitor, behavioral tests, dendritic spine imaging, chronic unpredictable stress model, MMP-9 enzymatic activity assay in human post mortem hippocampal tissue","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (pharmacology, imaging, biochemistry, human tissue), mechanistic link between 5-HT7R and MMP-9 in CA1 established in both mouse and human tissue","pmids":["35294881"],"is_preprint":false},{"year":2014,"finding":"5-HT7R is coupled to Gα12 protein in addition to Gs, and Gα12-mediated signaling activates small GTPases of the Rho family, providing a second major signaling arm for 5-HT7R independent of cAMP.","method":"Intracellular signaling assays (review synthesis of primary data cited in this review paper; primary data from other labs)","journal":"Frontiers in behavioral neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — review paper summarizing established findings from primary literature; G12/Rho coupling mentioned as established but primary experimental methods not described within this abstract","pmids":["25324743"],"is_preprint":false},{"year":2019,"finding":"miR-29a post-transcriptionally regulates 5-HT7R expression by binding its 3'UTR (confirmed by luciferase assay), downregulating 5-HT7R mRNA in hippocampal neurons; miR-29a overexpression impairs 5-HT7R-dependent neurite elongation and remodeling via inhibition of ERK signaling; in vivo, upregulation of miR-29a during hippocampal development parallels downregulation of 5-HT7R.","method":"Luciferase 3'UTR reporter assay, miR-29a overexpression in hippocampal neurons, neurite morphometry, ERK pathway inhibition, in vivo developmental expression profiling","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct 3'UTR luciferase assay confirming miR-29a binding, functional rescue experiments, in vivo developmental validation; multiple orthogonal approaches","pmids":["31292861"],"is_preprint":false},{"year":2014,"finding":"5-HT7R activation increases expression and basal phosphorylation (at Tyr816) of full-length TrkB in cortical neurons, SH-SY5Y cells, and RGC-5 cells; the effect involves both Gαs and Gα12 downstream pathways depending on the cell system, and occurs within 30 min of receptor activation.","method":"Primary cerebral cortical cultures, SH-SY5Y and RGC-5 cell lines, selective 5-HT7R agonist LP-12, Western blot for TrkB expression and phospho-TrkB (Tyr816), pathway inhibitors for Gαs and Gα12","journal":"Frontiers in behavioral neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Western blot with pathway inhibitors across multiple cell systems; single lab, no reconstitution or structural validation","pmids":["25426041"],"is_preprint":false},{"year":2009,"finding":"Methylphenidate administration to adolescent rats produced a marked increase in 5-HT7 (Htr7) receptor expression in the nucleus accumbens and increased synaptic contacts; a selective Htr7 antagonist fully counteracted MPH-reduced impulsive behavior and enhanced impulsivity when administered alone; 5-HT7 agonist-induced activation in striatal neuron primary cultures significantly increased neurite length, suggesting 5-HT7 mediates plastic remodeling of neuronal morphology.","method":"Adolescent rat MPH treatment, Htr7 expression analysis, behavioral impulsivity assay, selective Htr7 antagonist, striatal neuron primary culture with agonist, neurite length measurement","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological manipulation with in vitro neuronal morphology assay; behavioral and cellular phenotypes linked to 5-HT7 expression, single lab","pmids":["19243449"],"is_preprint":false},{"year":2020,"finding":"The Drosophila ortholog of 5-HT7 (d5-HT7), expressed specifically in mushroom body (MB) neurons, is required for olfactory associative learning in larvae; d5-HT7 mediates learning via cAMP-dependent signaling; spatio-temporal restriction of d5-HT7 expression to the MB neurons was sufficient to rescue olfactory learning deficits in d5-HT7 null larvae.","method":"Drosophila d5-HT7 null mutants, tissue-specific rescue with MB-specific expression of d5-HT7, olfactory conditioning assay, cAMP-PKA pathway dissection","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic null and tissue-specific rescue establishes necessity and sufficiency; ortholog in Drosophila, cAMP mechanism consistent with mammalian 5-HT7","pmids":["33277559"],"is_preprint":false}],"current_model":"HTR7 (5-HT7) is a seven-transmembrane Gs/G12-coupled GPCR that primarily signals through cAMP/PKA and, via EPAC-mTORC1, to regulate neuronal plasticity; it also activates Rho-family GTPases (Cdc42, RhoA) through Gα12 to drive cytoskeletal reorganization (neurite elongation, spine formation, synaptogenesis) mediated by CDK5, MAPK/ERK, and actin-binding proteins (cofilin); constitutive receptor activity (demonstrable as inverse agonism) contributes to spinogenesis and, via a G-protein-independent CDK5-dependent pathway, to Tau hyperphosphorylation; the receptor forms homodimers with highest affinity and 5-HT1A/5-HT7 heterodimers that attenuate 5-HT1A-Gi signaling and GIRK channel activity while enhancing MAPK activation; downstream effectors include TrkB (whose expression and phosphorylation are upregulated by 5-HT7R activation), MMP-9 (mediating depressive-like behavior in hippocampal CA1), and TRPA1 (mediating serotonergic itch peripherally); the receptor's cAMP signaling bifurcates into a PKA branch that constrains spinal respiratory plasticity and an EPAC-mTORC1 branch that drives phrenic motor facilitation; S100B interacts with 5-HT7R and negatively regulates its cAMP output in astrocytes; expression is post-transcriptionally suppressed by miR-29a via 3'UTR binding; the receptor mediates 5-HT-induced hypothermia, suppression of SCN photic responses, REM sleep regulation, inhibition of intestinal peristalsis via enteric neurons, anti-inflammatory macrophage polarization through myeloid CD11c cells, and both pronociceptive (peripheral, low-dose spinal) and antinociceptive (central sensitization context) pain modulation."},"narrative":{"mechanistic_narrative":"HTR7 (5-HT7) is a serotonin-activated G-protein-coupled receptor that couples to Gs to stimulate adenylyl cyclase and cAMP production, governing neuronal plasticity, thermoregulation, circadian and sleep physiology, gut motility, immune polarization, nociception, and itch [PMID:9303561, PMID:9298538, PMID:12529502]. The receptor exists as multiple C-terminal splice variants (h5-HT7a/b/d) that are all positively coupled to adenylyl cyclase, and it displays constitutive (agonist-independent) cAMP activity revealed by inverse agonists such as methiothepin [PMID:9303561, PMID:11906971]. Beyond classical Gs/cAMP signaling, 5-HT7R couples to Gα12 to activate Rho-family GTPases, providing a parallel cytoskeletal signaling arm [PMID:25324743]. Through these branches the receptor drives neurite/axonal elongation, dendritic spine formation, and synaptogenesis via downstream effectors including mTOR, CDK5, Cdc42, ERK, and the actin regulator cofilin [PMID:28122114, PMID:25814944]. The cAMP signal bifurcates functionally: a PKA branch that constrains spinal phrenic motor plasticity and an EPAC→mTORC1 branch that drives phrenic motor facilitation, the latter also requiring new TrkB synthesis and PI3K/AKT signaling [PMID:21242254, PMID:23850591, PMID:26269554]. 5-HT7R activity upregulates TrkB expression and phosphorylation [PMID:25426041], and its constitutive, G-protein-independent activity drives CDK5-dependent Tau hyperphosphorylation, neurotoxicity, and memory impairment [PMID:32841723]. The receptor forms homodimers (highest affinity) and 5-HT1A/5-HT7 heterodimers that suppress 5-HT1A-Gi signaling and GIRK currents while enhancing MAPK activation [PMID:22357950]. In the periphery and immune system it promotes M2 anti-inflammatory macrophage polarization, protects against intestinal inflammation via CD11c+ myeloid cells, and triggers serotonergic itch by opening TRPA1 [PMID:23355731, PMID:25072499, PMID:26074006]. Receptor output is negatively modulated by direct binding of S100B, which dampens cAMP accumulation, and its expression is post-transcriptionally suppressed by miR-29a via 3'UTR binding [PMID:26499172, PMID:31292861].","teleology":[{"year":1994,"claim":"Established that 5-HT7 receptor signaling functionally modulates neuronal currents through the cAMP/PKA cascade, defining its core transduction mechanism in native neurons.","evidence":"Whole-cell voltage-clamp in rat SCN neurons with selective agonists/antagonists, forskolin, cAMP analogs, and PKA inhibitor","pmids":["7965836"],"confidence":"High","gaps":["Did not identify the receptor isoform or Gs subunit directly","Restricted to GABAA current modulation in one nucleus"]},{"year":1997,"claim":"Demonstrated that the receptor is encoded as multiple C-terminal splice variants all positively coupled to adenylyl cyclase, establishing Gs coupling at the molecular level and broad tissue expression.","evidence":"Molecular cloning and heterologous expression (NIH-3T3, HEK293) with radioligand binding and cAMP functional assays plus tissue mRNA analysis","pmids":["9303561","9298538"],"confidence":"High","gaps":["Functional differences between splice variants not resolved","No structural information on the receptor"]},{"year":1997,"claim":"Identified 5-HT7 as the principal mediator of serotonergic suppression of SCN photic responses, linking receptor function to circadian physiology.","evidence":"Single-unit electrophysiology in hamster SCN slices with selective 5-HT7 vs 5-HT1A antagonists","pmids":["9175892"],"confidence":"High","gaps":["Downstream signaling to clock machinery not defined"]},{"year":2002,"claim":"Revealed that the receptor possesses constitutive (agonist-independent) adenylyl cyclase activity, expanding its mechanism to ligand-independent signaling demonstrable by inverse agonism.","evidence":"Adenylyl cyclase and inverse agonism profiling in transfected HEK293 membranes across all three splice variants","pmids":["11906971"],"confidence":"High","gaps":["Physiological consequences of constitutive activity not yet shown in this study"]},{"year":2003,"claim":"Used genetic knockout to assign 5-HT-induced hypothermia and intestinal peristalsis inhibition to 5-HT7, establishing in vivo physiological roles and an allosteric lipid modulator (oleamide).","evidence":"5-HT7 knockout mice with thermoregulatory challenge; guinea-pig ileum peristalsis organ-bath assays with SB-269970","pmids":["12529502","12711620"],"confidence":"High","gaps":["Signaling pathway linking receptor to thermoregulation/motility not defined","Oleamide mechanism remains independent of receptor"]},{"year":2004,"claim":"Dissected the dose-dependent contributions of 5-HT7 versus 5-HT1A to hypothermia, showing 5-HT7 dominates at physiologically relevant agonist concentrations.","evidence":"Combined knockout and selective antagonist dose-response thermoregulation in mice","pmids":["15033384"],"confidence":"High","gaps":["Receptor circuitry mediating temperature drop not mapped"]},{"year":2005,"claim":"Connected 5-HT7 to antidepressant-like behavior, REM sleep regulation, spinal nociceptive anatomy, and enteric peristalsis, broadening its behavioral and peripheral physiology.","evidence":"Knockout/antagonist behavioral and sleep EEG studies; spinal cord immunoEM localization; ileal peristalsis with confocal localization","pmids":["16018977","16082681","16285955"],"confidence":"High","gaps":["Molecular signaling underlying behavioral phenotypes not established","Spinal localization study lacked functional validation in same work"]},{"year":2008,"claim":"Correlated 5-HT7 Gs/cAMP intrinsic efficacy with antinociception, directly tying the receptor's signaling output to a behavioral pain outcome.","evidence":"Parallel in vitro cAMP assays in HEK-293F (human receptor) and in vivo capsaicin hypersensitivity with selective agonists/antagonists","pmids":["19118950"],"confidence":"High","gaps":["Site of antinociceptive action (central vs peripheral) not fully resolved"]},{"year":2009,"claim":"Linked 5-HT7 to hippocampus-dependent spatial memory and to plastic neuronal remodeling, while excluding adult neurogenesis as the mechanism.","evidence":"Knockout/antagonist behavioral paradigms with BrdU; adolescent rat methylphenidate study with striatal neurite assays","pmids":["19447277","19243449"],"confidence":"High","gaps":["Molecular signaling for memory role not defined","Methylphenidate-receptor link is correlative in vivo"]},{"year":2011,"claim":"Defined opposing spinal cAMP branches and synaptic circuit actions, showing 5-HT7-driven phrenic motor facilitation requires TrkB/PI3K and that it modulates hippocampal inhibitory transmission.","evidence":"Intrathecal pharmacology with TrkB siRNA/k252a/PI3K inhibitors and phrenic electrophysiology; whole-cell patch-clamp in rat hippocampal slices","pmids":["21242254","22204801"],"confidence":"High","gaps":["Source of new TrkB independent of BDNF unexplained","Presynaptic vs postsynaptic receptor populations not genetically resolved"]},{"year":2012,"claim":"Established that 5-HT7 forms homodimers and 5-HT1A/5-HT7 heterodimers that reshape signaling, suppressing 5-HT1A-Gi/GIRK output while enhancing MAPK.","evidence":"FRET dimerization affinity, Gi functional/GIRK recordings, internalization and MAPK assays in heterologous cells and hippocampal neurons","pmids":["22357950"],"confidence":"High","gaps":["Structural basis of dimer interface unknown","In vivo behavioral consequences of heterodimerization not tested here"]},{"year":2013,"claim":"Extended 5-HT7 function to immune and hepatic biology, mediating M2 macrophage polarization and cAMP/PKA-CREB/AKT-driven IGF-1 secretion in hepatocytes.","evidence":"Human macrophage polarization with selective antagonists; isolated rat hepatocyte biochemistry with antagonist reversal","pmids":["23355731","23578138"],"confidence":"Medium","gaps":["Receptor-proximal signaling in macrophages not detailed","Single-lab studies without genetic confirmation"]},{"year":2014,"claim":"Identified a second signaling arm (Gα12/Rho), an S100B negative regulator, and TrkB upregulation, diversifying the receptor's effector landscape beyond cAMP.","evidence":"Review synthesis of G12/Rho coupling; Co-IP and cAMP assays for S100B in HeLa and astrocytes with transgenic mice; Western blots of TrkB/phospho-TrkB across cell lines with Gs/G12 inhibitors","pmids":["25324743","26499172","25426041"],"confidence":"Medium","gaps":["G12/Rho coupling cited from review, primary methods not detailed","S100B interaction structure unknown","TrkB phosphorylation mechanism not fully mapped"]},{"year":2015,"claim":"Mechanistically resolved 5-HT7-driven structural plasticity (spinogenesis, neurite/axon elongation) through CDK5/Cdc42/mTOR/ERK and cofilin, and separated the spinal cAMP signal into PKA-constraining and EPAC-mTORC1-facilitating branches; also established cerebellar plasticity, itch via TRPA1, and intestinal anti-inflammatory roles.","evidence":"Knockout/agonist neuron cultures with effector inhibitors and microfluidic axon assays; intrathecal EPAC/PKA/mTORC1 pharmacology and phrenic electrophysiology; cerebellar slice electrophysiology; HTR7/TRPA1 double knockout itch models; DSS colitis with bone marrow chimera","pmids":["28122114","25814944","26269554","26482421","26074006","25072499"],"confidence":"High","gaps":["How cAMP selectively routes to PKA vs EPAC not defined","Direct receptor-TRPA1 coupling mechanism unresolved"]},{"year":2019,"claim":"Established miR-29a as a post-transcriptional brake on receptor expression that limits 5-HT7-dependent neurite remodeling via ERK during hippocampal development.","evidence":"Luciferase 3'UTR reporter, miR-29a overexpression with neurite morphometry and ERK inhibition, in vivo developmental expression profiling","pmids":["31292861"],"confidence":"High","gaps":["Upstream regulators of miR-29a not identified"]},{"year":2020,"claim":"Demonstrated that constitutive, G-protein-independent 5-HT7 activity physically engages CDK5 to drive Tau hyperphosphorylation and neurotoxicity, and confirmed conserved cAMP-dependent learning function via the Drosophila ortholog.","evidence":"Co-IP, Tau[R406W] mouse model, constitutive-activity blockade, prefrontal shRNA knockdown with LTP and memory tests; Drosophila d5-HT7 null and MB-specific rescue olfactory conditioning","pmids":["32841723","33277559"],"confidence":"High","gaps":["Structural basis of G-protein-independent CDK5 coupling unknown","Relevance to human tauopathy not directly tested"]},{"year":2022,"claim":"Linked 5-HT7 activation in hippocampal CA1 to depressive-like behavior through an MMP-9-dependent pathway, with corroborating elevated MMP-9 in human depressed hippocampus.","evidence":"LP-211 agonist with MMP-9 inhibitor, behavioral tests, dendritic spine imaging, chronic stress model, and human post-mortem MMP-9 activity assays","pmids":["35294881"],"confidence":"High","gaps":["Signaling steps connecting receptor to MMP-9 induction not defined"]},{"year":null,"claim":"How the receptor's cAMP output is selectively partitioned between PKA and EPAC branches, and the structural determinants of its G-protein-independent CDK5 coupling and dimerization, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of the receptor or its dimer/effector interfaces","Mechanism of branch selection between PKA and EPAC unknown","No direct disease-causing mutation established in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,3,11]},{"term_id":"GO:0009975","term_label":"cyclase activity","supporting_discovery_ids":[2,3,4,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,20]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,11,24,28]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[14,21,22,25]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,19]}],"complexes":["5-HT1A/5-HT7 heterodimer","5-HT7 homodimer"],"partners":["HTR1A","S100B","CDK5","TRKB","TRPA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P34969","full_name":"5-hydroxytryptamine receptor 7","aliases":["5-HT-X","Serotonin receptor 7"],"length_aa":479,"mass_kda":53.6,"function":"G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:35714614, PubMed:8226867). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:35714614, PubMed:8226867). HTR7 is coupled to G(s) G alpha proteins and mediates activation of adenylate cyclase activity (PubMed:35714614)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P34969/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HTR7","classification":"Not Classified","n_dependent_lines":11,"n_total_lines":1208,"dependency_fraction":0.009105960264900662},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HTR7","total_profiled":1310},"omim":[{"mim_id":"605526","title":"ALZHEIMER DISEASE 6","url":"https://www.omim.org/entry/605526"},{"mim_id":"182137","title":"5-@HYDROXYTRYPTAMINE RECEPTOR 7; HTR7","url":"https://www.omim.org/entry/182137"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"parathyroid gland","ntpm":12.3},{"tissue":"testis","ntpm":8.2}],"url":"https://www.proteinatlas.org/search/HTR7"},"hgnc":{"alias_symbol":["5-HT7"],"prev_symbol":[]},"alphafold":{"accession":"P34969","domains":[{"cath_id":"1.20.1070.10","chopping":"79-273_333-389","consensus_level":"high","plddt":91.6111,"start":79,"end":389}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P34969","model_url":"https://alphafold.ebi.ac.uk/files/AF-P34969-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P34969-F1-predicted_aligned_error_v6.png","plddt_mean":73.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HTR7","jax_strain_url":"https://www.jax.org/strain/search?query=HTR7"},"sequence":{"accession":"P34969","fasta_url":"https://rest.uniprot.org/uniprotkb/P34969.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P34969/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P34969"}},"corpus_meta":[{"pmid":"15559250","id":"PMC_15559250","title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research.","date":"2004","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15559250","citation_count":269,"is_preprint":false},{"pmid":"16018977","id":"PMC_16018977","title":"5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16018977","citation_count":223,"is_preprint":false},{"pmid":"7647964","id":"PMC_7647964","title":"Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain.","date":"1995","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/7647964","citation_count":212,"is_preprint":false},{"pmid":"19649616","id":"PMC_19649616","title":"The 5-HT7 receptor and disorders of the nervous system: an overview.","date":"2009","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19649616","citation_count":207,"is_preprint":false},{"pmid":"23355731","id":"PMC_23355731","title":"Serotonin skews human macrophage polarization through HTR2B and HTR7.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23355731","citation_count":191,"is_preprint":false},{"pmid":"15033384","id":"PMC_15033384","title":"8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.","date":"2004","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15033384","citation_count":165,"is_preprint":false},{"pmid":"22357950","id":"PMC_22357950","title":"Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22357950","citation_count":164,"is_preprint":false},{"pmid":"10664612","id":"PMC_10664612","title":"5-HT7 receptors: current knowledge and future prospects.","date":"2000","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10664612","citation_count":162,"is_preprint":false},{"pmid":"20923682","id":"PMC_20923682","title":"Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.","date":"2010","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/20923682","citation_count":160,"is_preprint":false},{"pmid":"26074006","id":"PMC_26074006","title":"HTR7 Mediates Serotonergic Acute and Chronic Itch.","date":"2015","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/26074006","citation_count":147,"is_preprint":false},{"pmid":"12529502","id":"PMC_12529502","title":"No hypothermic response to serotonin in 5-HT7 receptor knockout mice.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12529502","citation_count":137,"is_preprint":false},{"pmid":"21424680","id":"PMC_21424680","title":"Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.","date":"2011","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21424680","citation_count":134,"is_preprint":false},{"pmid":"23500207","id":"PMC_23500207","title":"Multiple roles of serotonin in pain control mechanisms--implications of 5-HT₇ and other 5-HT receptor types.","date":"2013","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23500207","citation_count":130,"is_preprint":false},{"pmid":"28901281","id":"PMC_28901281","title":"Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System.","date":"2018","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28901281","citation_count":128,"is_preprint":false},{"pmid":"26300776","id":"PMC_26300776","title":"The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory.","date":"2015","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26300776","citation_count":127,"is_preprint":false},{"pmid":"14965246","id":"PMC_14965246","title":"5-HT7 receptors.","date":"2004","source":"Current drug targets. CNS and neurological disorders","url":"https://pubmed.ncbi.nlm.nih.gov/14965246","citation_count":125,"is_preprint":false},{"pmid":"9175892","id":"PMC_9175892","title":"5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons.","date":"1997","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9175892","citation_count":120,"is_preprint":false},{"pmid":"19118950","id":"PMC_19118950","title":"5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice.","date":"2008","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/19118950","citation_count":114,"is_preprint":false},{"pmid":"19447277","id":"PMC_19447277","title":"The 5-HT7 receptor is involved in allocentric spatial memory information processing.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19447277","citation_count":112,"is_preprint":false},{"pmid":"9298538","id":"PMC_9298538","title":"Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).","date":"1997","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9298538","citation_count":107,"is_preprint":false},{"pmid":"16082681","id":"PMC_16082681","title":"Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence.","date":"2005","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16082681","citation_count":99,"is_preprint":false},{"pmid":"25721336","id":"PMC_25721336","title":"Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.","date":"2015","source":"CNS drugs","url":"https://pubmed.ncbi.nlm.nih.gov/25721336","citation_count":98,"is_preprint":false},{"pmid":"24935787","id":"PMC_24935787","title":"Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.","date":"2014","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24935787","citation_count":94,"is_preprint":false},{"pmid":"25221471","id":"PMC_25221471","title":"5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.","date":"2014","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25221471","citation_count":93,"is_preprint":false},{"pmid":"24042216","id":"PMC_24042216","title":"The serotonin 5-HT7 receptors: two decades of research.","date":"2013","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24042216","citation_count":88,"is_preprint":false},{"pmid":"11906971","id":"PMC_11906971","title":"The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.","date":"2002","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11906971","citation_count":86,"is_preprint":false},{"pmid":"25324743","id":"PMC_25324743","title":"Cellular mechanisms of the 5-HT7 receptor-mediated signaling.","date":"2014","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25324743","citation_count":85,"is_preprint":false},{"pmid":"16098671","id":"PMC_16098671","title":"Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test.","date":"2005","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/16098671","citation_count":78,"is_preprint":false},{"pmid":"21242254","id":"PMC_21242254","title":"Spinal 5-HT7 receptor activation induces long-lasting phrenic motor facilitation.","date":"2011","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21242254","citation_count":77,"is_preprint":false},{"pmid":"28122114","id":"PMC_28122114","title":"Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28122114","citation_count":74,"is_preprint":false},{"pmid":"25072499","id":"PMC_25072499","title":"Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract.","date":"2014","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25072499","citation_count":71,"is_preprint":false},{"pmid":"12215375","id":"PMC_12215375","title":"5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons.","date":"2002","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12215375","citation_count":71,"is_preprint":false},{"pmid":"18361484","id":"PMC_18361484","title":"(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.","date":"2008","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18361484","citation_count":69,"is_preprint":false},{"pmid":"17869441","id":"PMC_17869441","title":"The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior.","date":"2007","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17869441","citation_count":68,"is_preprint":false},{"pmid":"12084412","id":"PMC_12084412","title":"Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum.","date":"2002","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/12084412","citation_count":68,"is_preprint":false},{"pmid":"11514061","id":"PMC_11514061","title":"Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus.","date":"2001","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/11514061","citation_count":66,"is_preprint":false},{"pmid":"7965836","id":"PMC_7965836","title":"Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones.","date":"1994","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7965836","citation_count":64,"is_preprint":false},{"pmid":"16285955","id":"PMC_16285955","title":"5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum.","date":"2005","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16285955","citation_count":63,"is_preprint":false},{"pmid":"19243449","id":"PMC_19243449","title":"Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19243449","citation_count":61,"is_preprint":false},{"pmid":"17267119","id":"PMC_17267119","title":"The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17267119","citation_count":60,"is_preprint":false},{"pmid":"24805037","id":"PMC_24805037","title":"Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24805037","citation_count":59,"is_preprint":false},{"pmid":"25814944","id":"PMC_25814944","title":"Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics.","date":"2015","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25814944","citation_count":57,"is_preprint":false},{"pmid":"9179401","id":"PMC_9179401","title":"Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat.","date":"1997","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9179401","citation_count":54,"is_preprint":false},{"pmid":"18332680","id":"PMC_18332680","title":"Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.","date":"2008","source":"Behavioural pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18332680","citation_count":54,"is_preprint":false},{"pmid":"24486730","id":"PMC_24486730","title":"Serotonergic 5-HT7 receptors and cognition.","date":"2014","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24486730","citation_count":51,"is_preprint":false},{"pmid":"23850591","id":"PMC_23850591","title":"Spinal 5-HT7 receptors and protein kinase A constrain intermittent hypoxia-induced phrenic long-term facilitation.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23850591","citation_count":51,"is_preprint":false},{"pmid":"11750917","id":"PMC_11750917","title":"[3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11750917","citation_count":51,"is_preprint":false},{"pmid":"22801295","id":"PMC_22801295","title":"5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.","date":"2012","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22801295","citation_count":50,"is_preprint":false},{"pmid":"18301795","id":"PMC_18301795","title":"5-HT7 receptor antagonists as a new class of antidepressants.","date":"2007","source":"Drug news & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/18301795","citation_count":49,"is_preprint":false},{"pmid":"9178857","id":"PMC_9178857","title":"Expression of 5-HT7 receptor mRNA in rat brain during postnatal development.","date":"1997","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/9178857","citation_count":48,"is_preprint":false},{"pmid":"22204801","id":"PMC_22204801","title":"5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area.","date":"2011","source":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","url":"https://pubmed.ncbi.nlm.nih.gov/22204801","citation_count":48,"is_preprint":false},{"pmid":"24698823","id":"PMC_24698823","title":"Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.","date":"2014","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24698823","citation_count":46,"is_preprint":false},{"pmid":"7601444","id":"PMC_7601444","title":"Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7601444","citation_count":46,"is_preprint":false},{"pmid":"35294881","id":"PMC_35294881","title":"Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behavior.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35294881","citation_count":46,"is_preprint":false},{"pmid":"15339860","id":"PMC_15339860","title":"Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.","date":"2004","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15339860","citation_count":46,"is_preprint":false},{"pmid":"19326916","id":"PMC_19326916","title":"Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.","date":"2009","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19326916","citation_count":46,"is_preprint":false},{"pmid":"24681431","id":"PMC_24681431","title":"The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness.","date":"2014","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24681431","citation_count":45,"is_preprint":false},{"pmid":"26269554","id":"PMC_26269554","title":"Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling.","date":"2015","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/26269554","citation_count":45,"is_preprint":false},{"pmid":"25628528","id":"PMC_25628528","title":"The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.","date":"2015","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25628528","citation_count":44,"is_preprint":false},{"pmid":"26482421","id":"PMC_26482421","title":"The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK.","date":"2015","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26482421","citation_count":43,"is_preprint":false},{"pmid":"22415605","id":"PMC_22415605","title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.","date":"2012","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/22415605","citation_count":42,"is_preprint":false},{"pmid":"12711351","id":"PMC_12711351","title":"5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive 'stigmoid body'-like structure in developing rat brains.","date":"2003","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12711351","citation_count":42,"is_preprint":false},{"pmid":"17439430","id":"PMC_17439430","title":"5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.","date":"2007","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17439430","citation_count":42,"is_preprint":false},{"pmid":"33679481","id":"PMC_33679481","title":"Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.","date":"2021","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33679481","citation_count":41,"is_preprint":false},{"pmid":"24622785","id":"PMC_24622785","title":"Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview.","date":"2014","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24622785","citation_count":41,"is_preprint":false},{"pmid":"17897083","id":"PMC_17897083","title":"5-HT7 receptor ligands: recent developments and potential therapeutic applications.","date":"2007","source":"Mini reviews in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17897083","citation_count":41,"is_preprint":false},{"pmid":"23578138","id":"PMC_23578138","title":"Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.","date":"2013","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/23578138","citation_count":40,"is_preprint":false},{"pmid":"26499172","id":"PMC_26499172","title":"S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26499172","citation_count":38,"is_preprint":false},{"pmid":"9303561","id":"PMC_9303561","title":"Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9303561","citation_count":38,"is_preprint":false},{"pmid":"26554929","id":"PMC_26554929","title":"Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26554929","citation_count":38,"is_preprint":false},{"pmid":"12711620","id":"PMC_12711620","title":"5-HT7 receptors mediate the inhibitory effect of 5-HT on peristalsis in the isolated guinea-pig ileum.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12711620","citation_count":37,"is_preprint":false},{"pmid":"23995300","id":"PMC_23995300","title":"Modulation of 5-HT7 receptor: effect on object recognition performances in mice.","date":"2013","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23995300","citation_count":36,"is_preprint":false},{"pmid":"19447286","id":"PMC_19447286","title":"Memory time-course: mRNA 5-HT1A and 5-HT7 receptors.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19447286","citation_count":36,"is_preprint":false},{"pmid":"20236348","id":"PMC_20236348","title":"Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.","date":"2010","source":"Headache","url":"https://pubmed.ncbi.nlm.nih.gov/20236348","citation_count":36,"is_preprint":false},{"pmid":"25642173","id":"PMC_25642173","title":"Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors.","date":"2015","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25642173","citation_count":35,"is_preprint":false},{"pmid":"25074446","id":"PMC_25074446","title":"5-HT7 receptor activation: procognitive and antiamnesic effects.","date":"2014","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25074446","citation_count":34,"is_preprint":false},{"pmid":"15476750","id":"PMC_15476750","title":"5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats.","date":"2004","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15476750","citation_count":34,"is_preprint":false},{"pmid":"25446573","id":"PMC_25446573","title":"Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents.","date":"2015","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446573","citation_count":34,"is_preprint":false},{"pmid":"10720076","id":"PMC_10720076","title":"Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10720076","citation_count":34,"is_preprint":false},{"pmid":"22609798","id":"PMC_22609798","title":"5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice.","date":"2012","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/22609798","citation_count":33,"is_preprint":false},{"pmid":"15726452","id":"PMC_15726452","title":"Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.","date":"2004","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15726452","citation_count":33,"is_preprint":false},{"pmid":"19702552","id":"PMC_19702552","title":"Therapeutic potential of 5-HT7 receptors in mood disorders.","date":"2009","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/19702552","citation_count":33,"is_preprint":false},{"pmid":"25565996","id":"PMC_25565996","title":"5-HT7 receptor signaling: improved therapeutic strategy in gut disorders.","date":"2014","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25565996","citation_count":32,"is_preprint":false},{"pmid":"34199418","id":"PMC_34199418","title":"Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34199418","citation_count":32,"is_preprint":false},{"pmid":"17316605","id":"PMC_17316605","title":"5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats.","date":"2007","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17316605","citation_count":32,"is_preprint":false},{"pmid":"10490701","id":"PMC_10490701","title":"Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10490701","citation_count":31,"is_preprint":false},{"pmid":"14578406","id":"PMC_14578406","title":"Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/14578406","citation_count":30,"is_preprint":false},{"pmid":"17258778","id":"PMC_17258778","title":"Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17258778","citation_count":30,"is_preprint":false},{"pmid":"33277559","id":"PMC_33277559","title":"Serotonin receptor 5-HT7 in Drosophila mushroom body neurons mediates larval appetitive olfactory learning.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33277559","citation_count":29,"is_preprint":false},{"pmid":"25426041","id":"PMC_25426041","title":"5-HT7 receptor activation promotes an increase in TrkB receptor expression and phosphorylation.","date":"2014","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25426041","citation_count":29,"is_preprint":false},{"pmid":"31292861","id":"PMC_31292861","title":"The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31292861","citation_count":29,"is_preprint":false},{"pmid":"25917322","id":"PMC_25917322","title":"The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia.","date":"2015","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25917322","citation_count":29,"is_preprint":false},{"pmid":"18167178","id":"PMC_18167178","title":"Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.","date":"2007","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18167178","citation_count":29,"is_preprint":false},{"pmid":"18083580","id":"PMC_18083580","title":"Novel quinazolinone derivatives as 5-HT7 receptor ligands.","date":"2007","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18083580","citation_count":28,"is_preprint":false},{"pmid":"26130632","id":"PMC_26130632","title":"Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human Colon.","date":"2015","source":"Journal of neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/26130632","citation_count":28,"is_preprint":false},{"pmid":"16572590","id":"PMC_16572590","title":"Ontogenetic distribution of 5-HT2C, 5-HT5A, and 5-HT7 receptors in the rat hippocampus.","date":"2006","source":"Gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/16572590","citation_count":28,"is_preprint":false},{"pmid":"32841723","id":"PMC_32841723","title":"Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor.","date":"2020","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32841723","citation_count":27,"is_preprint":false},{"pmid":"12523486","id":"PMC_12523486","title":"In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.","date":"2002","source":"Polish journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12523486","citation_count":27,"is_preprint":false},{"pmid":"12070528","id":"PMC_12070528","title":"SB-258741: a 5-HT7 receptor antagonist of potential clinical interest.","date":"2002","source":"CNS drug reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12070528","citation_count":26,"is_preprint":false},{"pmid":"15261279","id":"PMC_15261279","title":"Aminotriazine 5-HT7 antagonists.","date":"2004","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/15261279","citation_count":26,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52976,"output_tokens":9711,"usd":0.152297,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19851,"output_tokens":5464,"usd":0.117928,"stage2_stop_reason":"end_turn"},"total_usd":0.270225,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"5-HT7 receptor activation in rat suprachiasmatic nucleus neurons inhibits GABA-activated current (IGABA) via a cAMP-coupled signaling mechanism; the effect was blocked by ritanserin (a 5-HT7 antagonist) but not by pindolol (5-HT1A/B antagonist), and was mimicked by forskolin and 8-bromo-cAMP, with H-8 (PKA inhibitor) reducing the 5-HT effect, indicating 5-HT7 receptor couples to cAMP/PKA to modulate GABAA receptor currents.\",\n      \"method\": \"Whole-cell voltage-clamp recordings in rat SCN neurons with selective agonists, antagonists, and PKA inhibitors\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiology with pharmacological dissection, multiple orthogonal tools (agonists, antagonists, PKA inhibitor, cAMP analogs), replicating receptor-cAMP-PKA pathway\",\n      \"pmids\": [\"7965836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"5-HT7 receptors mediate serotonin's suppression of light-evoked (photic) responses in hamster suprachiasmatic nucleus neurons; effects of 5-HT, 8-OH-DPAT, and 5-CT were blocked by 5-HT7-active antagonists (ritanserin, clozapine) but not by selective 5-HT1A antagonists (WAY100635, p-MPPI) or the 5-HT1A/B/D antagonist cyanopindolol, establishing the 5-HT7 subtype as the principal mediator of serotonergic modulation of SCN photic responses.\",\n      \"method\": \"Single-unit electrophysiology in hamster SCN slices with pharmacological dissection using selective 5-HT7 and 5-HT1A antagonists; regional specificity confirmed in hippocampus and cerebellum controls\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiology with rigorous pharmacological dissection across multiple brain regions, clear pharmacological specificity\",\n      \"pmids\": [\"9175892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Two human 5-HT7 splice variants (h5-HT7a and h5-HT7b), differing in their intracellular C-terminal tail length, are both functionally expressed and positively coupled to adenylyl cyclase in NIH-3T3 cells; both variants are expressed in roughly equal amounts in various human brain regions.\",\n      \"method\": \"Molecular cloning, expression in NIH-3T3 cells, cAMP functional assay, Southern blot, and brain region mRNA analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct molecular cloning, heterologous expression, and functional (cAMP) assay confirming Gs coupling; replicated across splice variants\",\n      \"pmids\": [\"9303561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A truncated human 5-HT7 splice variant (h5-HT7b) was cloned, stably expressed in HEK293 cells, and shown to exhibit the same pharmacological profile and positive coupling to adenylyl cyclase as the long form (h5-HT7a); the receptor mRNA is found in brain, small intestine, and aorta.\",\n      \"method\": \"cDNA library cloning, stable HEK293 expression, radioligand binding ([3H]-5-CT), cAMP stimulation assay, RT-PCR\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in heterologous cells, binding and functional assays; replicated across both splice variants\",\n      \"pmids\": [\"9298538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"All three human 5-HT7 splice variants (h5-HT7a, h5-HT7b, h5-HT7d) display constitutive adenylyl cyclase activation; certain antagonists (e.g., methiothepin) act as inverse agonists by reducing basal cAMP, an effect blocked by the neutral antagonist mesulergine, demonstrating receptor-level constitutive activity independent of agonist stimulation.\",\n      \"method\": \"Stably and transiently transfected HEK293 cell membranes, adenylyl cyclase assay, inverse agonism profiling with 8 antagonists\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal pharmacological and biochemical assays on reconstituted receptor in defined cell system; all three variants tested\",\n      \"pmids\": [\"11906971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"5-HT-induced hypothermia is mediated by the 5-HT7 receptor: both 5-HT and 5-CT failed to induce hypothermia in 5-HT7 knockout mice at physiological doses. Oleamide, a lipid that allosterically interacts with 5-HT7, induced hypothermia equally in knockout and wild-type mice, indicating an independent/additional mechanism, and showed additive or greater-than-additive effects with 5-HT.\",\n      \"method\": \"5-HT7 receptor knockout mice, body temperature measurement, pharmacological challenge with 5-HT, 5-CT, and oleamide\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with rigorous pharmacological dissection, multiple agonists tested, mechanistic insight into allosteric modulation by oleamide\",\n      \"pmids\": [\"12529502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Both 5-HT7 and 5-HT1A receptors contribute to 8-OH-DPAT-induced hypothermia; at lower doses, hypothermia in wild-type mice is fully blocked by the selective 5-HT7 antagonist SB-269970 and is absent in 5-HT7 knockout mice, demonstrating that 5-HT7 is the dominant receptor at physiologically relevant concentrations while 5-HT1A mediates effects at higher doses.\",\n      \"method\": \"5-HT7 knockout and wild-type mice, selective antagonists (SB-269970, WAY-100135), body temperature measurement across dose ranges\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combined genetic knockout and selective pharmacology, dose-response analysis, replicated across rodent species\",\n      \"pmids\": [\"15033384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT7 receptor knockout mice display antidepressant-like behavior (decreased immobility in forced swim and tail suspension tests) and reduced REM sleep, mirroring effects of the selective 5-HT7 antagonist SB-269970; citalopram (SSRI) decreased immobility in both 5-HT7+/+ and 5-HT7−/− mice, indicating it utilizes an independent mechanism.\",\n      \"method\": \"5-HT7 knockout mice, forced swim test, tail suspension test, sleep EEG recording, selective antagonist SB-269970, SSRI citalopram\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout combined with pharmacological validation, multiple behavioral models and sleep measures, independent replication of antidepressant-like phenotype\",\n      \"pmids\": [\"16018977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT7 receptors are localized presynaptically (on peptidergic primary afferent terminals and intrinsic axons, ~60% of labeling in lamina I) and postsynaptically (on peptidergic cell bodies and dendrites) in the rat dorsal spinal cord, and also in astrocytes (~17–20%), providing morphological basis for 5-HT7 involvement in nociceptive processing.\",\n      \"method\": \"Immunocytochemistry and electron microscopy on rat lumbar spinal cord\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — detailed subcellular localization by electron microscopy, single-lab study with quantitative analysis, no direct functional validation in same paper\",\n      \"pmids\": [\"16082681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT7 receptors mediate inhibition of peristalsis in the guinea-pig ileum: the selective antagonist SB-269970-A concentration-dependently antagonized the 5-HT- or 5-CT-induced increase in the threshold required to trigger peristalsis and could restore blocked peristalsis.\",\n      \"method\": \"Isolated guinea-pig ileum peristalsis assay, selective 5-HT7 antagonist SB-269970-A and methiothepin, 5-HT2/3/4 receptor blockade as background\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional organ-bath pharmacology with selective antagonist, single lab\",\n      \"pmids\": [\"12711620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT7 receptors expressed on myenteric neurons (including descending/inhibitory neurons containing nNOS/VIP and after-hyperpolarizing neurons) modulate circular muscle accommodation during peristalsis in the guinea-pig ileum; SB-269970 increased threshold pressure and reduced accommodation.\",\n      \"method\": \"Immunohistochemistry, confocal microscopy, isolated ileal peristalsis assay with SB-269970\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combined localization (confocal) and functional pharmacology in same organ, single lab\",\n      \"pmids\": [\"16285955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"5-HT7 receptor agonists (AS-19, E-55888) dose-dependently reduced capsaicin-induced mechanical hypersensitivity in mice; the effect was blocked by 5-HT7 antagonists but not by 5-HT1A antagonist WAY-100635. The order of antinociceptive efficacy matched their in vitro efficacy to stimulate cAMP in HEK-293F cells expressing the human 5-HT7 receptor, establishing a direct correlation between 5-HT7 Gs/cAMP intrinsic efficacy and antinociception.\",\n      \"method\": \"In vitro cAMP assay in HEK-293F cells (human 5-HT7 receptor), radioligand binding, in vivo capsaicin mechanical hypersensitivity model with selective agonists and antagonists\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — parallel in vitro functional assay (cAMP, binding) and in vivo pharmacology with multiple selective compounds, mechanistic correlation between cAMP efficacy and behavior\",\n      \"pmids\": [\"19118950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"5-HT7 receptor-deficient mice show selective impairment in allocentric (hippocampus-dependent) spatial memory but intact egocentric (striatum-dependent) memory; identical hippocampal neurogenesis (BrdU) in knockout and wild-type mice indicates the spatial memory role is independent of adult neurogenesis.\",\n      \"method\": \"5-HT7 knockout mice, novel location/object test, Barnes maze, BrdU immunohistochemistry; pharmacological confirmation with SB-269970 in C57BL/6J mice\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with pharmacological replication, multiple behavioral paradigms, neurogenesis ruled out as mechanism\",\n      \"pmids\": [\"19447277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Spinal 5-HT7 receptor activation by intrathecal AS-19 elicits long-lasting phrenic motor facilitation (PMF >120 min) via a signaling pathway requiring new TrkB synthesis and activity (blocked by k252a and TrkB siRNA) and downstream PI3K/AKT activation, but not BDNF synthesis — a mechanism distinct from 5-HT2 receptor-dependent PMF.\",\n      \"method\": \"Intrathecal agonist/antagonist injections in anesthetized rats, TrkB siRNA, k252a (TrkB inhibitor), PI3K and MEK pathway inhibitors, phrenic nerve electrophysiology\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal interventions (pharmacology, siRNA, kinase inhibitors) in the same system converging on TrkB-PI3K pathway\",\n      \"pmids\": [\"21242254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"5-HT7 receptor activation in the hippocampal CA1 area increases the frequency (but not amplitude) of spontaneous IPSCs in pyramidal neurons by two mechanisms: (1) enhancement of excitatory glutamatergic input to GABAergic interneurons (likely via presynaptic 5-HT7 receptors, partially TTX- and kynurenic acid-sensitive) and (2) direct excitation of interneurons increasing GABA release (TTX-resistant component).\",\n      \"method\": \"Whole-cell patch-clamp recordings in rat hippocampal slices, 5-CT + WAY-100635 (to isolate 5-HT7), TTX, kynurenic acid, selective 5-HT7 antagonist\",\n      \"journal\": \"Journal of physiology and pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiology with pharmacological dissection, TTX/kynurenic acid experiments separating two distinct mechanisms\",\n      \"pmids\": [\"22204801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"5-HT1A and 5-HT7 receptors form heterodimers (and respective homodimers) both in vitro and in vivo; 5-HT7-5-HT7 homodimers have the highest affinity for complex formation, followed by 5-HT7-5-HT1A heterodimers, then 5-HT1A-5-HT1A homodimers. Heterodimerization decreases 5-HT1A-mediated Gi protein activation and GIRK channel activity without affecting 5-HT7 signaling, promotes 5-HT1A receptor internalization, enhances 5-HT1A-mediated MAPK activation, and is physiologically relevant in hippocampal neurons.\",\n      \"method\": \"FRET-based assays (homo/heterodimer affinity), Gi functional assay, GIRK channel recordings in heterologous system and hippocampal neurons, internalization assay, MAPK assay; 5-HT7 expression tracked developmentally\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (FRET, electrophysiology, functional signaling, internalization), validated in native neurons, rigorous mechanistic dissection\",\n      \"pmids\": [\"22357950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HTR7 (5-HT7 receptor) mediates serotonin-induced macrophage polarization toward M2 (anti-inflammatory) state: 5-HT7 alone mediates inhibition of LPS-induced proinflammatory cytokine release, and together with 5-HT2B mediates upregulation of M2-associated genes; blockade of 5-HT7 (and 5-HT2B) during monocyte-to-macrophage differentiation preferentially reduced M2 polarization markers.\",\n      \"method\": \"Human macrophage culture, selective receptor antagonists (5-HT7 and 5-HT2B), cytokine ELISA, gene expression analysis, in vitro polarization assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with selective antagonists in primary human cells, two orthogonal readouts (cytokines and gene expression), single lab\",\n      \"pmids\": [\"23355731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"5-HT7R activation in hepatocytes stimulates cAMP/PKA activity, phospho-CREB, and pERK/pAKT signaling, leading to IGF-1 synthesis and secretion; all effects were reversed by the 5-HT7 antagonist SB269970, demonstrating a functional 5-HT7 receptor coupled to cAMP/PKA and CREB/AKT in hepatocytes.\",\n      \"method\": \"Isolated rat hepatocytes, PCR/sequencing/Western blot for receptor expression, ELISA and cAMP/PKA assay, phospho-protein Western blots, antagonist reversal\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical assays in primary hepatocytes, antagonist reversal as specificity control, single lab\",\n      \"pmids\": [\"23578138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Spinal 5-HT7 receptor activation constrains acute intermittent hypoxia (AIH)-induced phrenic long-term facilitation (pLTF) via PKA: intrathecal 5-HT7 antagonist (SB-269970) or PKA inhibitor (KT-5720) both enhanced pLTF, while PKA activation (8-br-cAMP) blunted pLTF, identifying a Gs/PKA signaling branch that negatively regulates 5-HT2-dependent spinal motor plasticity.\",\n      \"method\": \"Intrathecal injections in anesthetized rats, selective 5-HT7 antagonist, PKA inhibitor and activator, phrenic nerve electrophysiology\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — pharmacological and biochemical dissection with selective agents for 5-HT7, PKA inhibitor and activator converging on same result; mechanistic contrast with prior facilitation paper\",\n      \"pmids\": [\"23850591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT7 receptor is critically involved in acute and chronic intestinal inflammation: expressed on CD11c/CD86-positive myeloid cells in the large intestine, 5-HT7R expression increased after colitis induction; genetic ablation or pharmacological blockade worsened colitis severity, while receptor stimulation was anti-inflammatory; bone marrow chimera experiments demonstrated that 5-HT7R on hematopoietic (CD11c+) cells mediates this effect.\",\n      \"method\": \"5-HT7R knockout mice, DSS acute/chronic colitis model, pharmacological agonist/antagonist treatment, bone marrow chimera, MRI, histology, immunophenotyping\",\n      \"journal\": \"Inflammatory bowel diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout, bone marrow chimera (cell-type specificity), pharmacological modulation, and multiple disease readouts in same study\",\n      \"pmids\": [\"25072499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"S100B, a Ca2+-binding protein, physically interacts with the 5-HT7 receptor and negatively regulates 5-HT7-mediated cAMP accumulation in transfected HeLa cells and mouse cortical astrocytes; S100B overexpression causes brain-region-specific dysregulation of cAMP and depressive-like behavior in female mice, reversible by 5-HT7 blockade.\",\n      \"method\": \"Co-immunoprecipitation/interaction assay, cAMP accumulation in transfected HeLa cells and primary astrocytes, S100B transgenic mice, forced swim test, pharmacological blockade with SB269970\",\n      \"journal\": \"European neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding interaction plus functional cAMP assay in two cell systems, transgenic mouse behavioral validation, single lab\",\n      \"pmids\": [\"26499172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"5-HT7R activation promotes formation of dendritic spines and synaptogenesis in postnatal cortical and striatal neurons via CDK5 and small GTPase Cdc42 as downstream effectors; neurons from 5-HT7R knockout mice or pharmacologically blocked receptors have decreased spine numbers, indicating constitutive 5-HT7R activity contributes to spinogenesis.\",\n      \"method\": \"Primary cortical/striatal neuron cultures, selective agonist LP-211, 5-HT7R knockout neurons, antagonist treatment, confocal imaging of dendritic spines, CDK5 and Cdc42 inhibitors\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout, pharmacological agonist/antagonist, and downstream effector inhibitors converging on spine density phenotype; multiple neuronal populations\",\n      \"pmids\": [\"28122114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"5-HT7R activation stimulates neurite/axonal elongation through multiple signaling pathways: mTOR, Rho GTPase Cdc42, CDK5, and ERK, which converge on actin cytoskeleton reorganization; LP-211 treatment altered expression profile of cofilin (actin-binding protein), and axonal elongation was confirmed using microfluidic chambers separating axons from soma/dendrites.\",\n      \"method\": \"Primary cortical/hippocampal/striatal neuron cultures, selective agonist LP-211, pharmacological inhibitors of mTOR/Cdc42/CDK5/ERK, 2D-Western blot for cofilin, microfluidic chamber assay for axonal elongation, actin polymerization drugs\",\n      \"journal\": \"Frontiers in behavioral neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple signaling pathway dissections with orthogonal inhibitors, actin biochemistry, microfluidic spatial separation of axonal compartment, multiple neuronal cell types\",\n      \"pmids\": [\"25814944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HTR7 is a key mediator of serotonergic acute and chronic itch: HTR7 activation promotes opening of the ion channel TRPA1, triggering itch behaviors; acute itch from serotonin or SSRI required both HTR7 and TRPA1; in a mouse model of atopic dermatitis, mice lacking HTR7 or TRPA1 showed reduced scratching and skin lesion severity.\",\n      \"method\": \"Genetic screen across mouse strains for itch co-regulated transcripts, HTR7 and TRPA1 knockout mice, serotonin/SSRI-induced itch behavioral assay, atopic dermatitis model\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockouts of both HTR7 and TRPA1, multiple itch models (acute and chronic), epistatic interaction established between HTR7 and TRPA1\",\n      \"pmids\": [\"26074006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Spinal 5-HT7 receptor-induced phrenic motor facilitation is mediated by EPAC (exchange protein activated by cAMP), not PKA: EPAC inhibitor (ESI-05) abolished 5-HT7 agonist-induced PMF, while PKA inhibitor (KT-5720) did not; direct EPAC activation was sufficient to elicit PMF; mTORC1 is required downstream, as intrathecal rapamycin abolished both 5-HT7- and EPAC-induced PMF, establishing a 5-HT7 → cAMP → EPAC → mTORC1 pathway for spinal motor plasticity.\",\n      \"method\": \"Intrathecal agonist injections in anesthetized rats, selective EPAC inhibitor (ESI-05), PKA inhibitor (KT-5720), EPAC activator (8-pCPT-2'-Me-cAMP), mTORC1 inhibitor (rapamycin), phrenic nerve electrophysiology\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal pharmacological interventions (EPAC inhibitor, PKA inhibitor, direct EPAC activator, mTORC1 inhibitor) establishing linear pathway; direct sufficiency test included\",\n      \"pmids\": [\"26269554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"5-HT7R activation induces cerebellar long-term depression (LTD) at the parallel fiber-Purkinje cell synapse via a postsynaptic PKC-MAPK signaling pathway; a 5-HT7R antagonist abolished standard parallel fiber-induced LTD, and a 5-HT7R agonist impaired LTP induced by 1 Hz stimulation, demonstrating 5-HT7R as a bidirectional regulator of cerebellar synaptic plasticity.\",\n      \"method\": \"Patch-clamp recordings in cerebellar slices of adult mice, selective 5-HT7R agonist LP-211, antagonist, PKC and MAPK inhibitors\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiology with pathway inhibitors (PKC, MAPK) and selective pharmacology establishing postsynaptic mechanism; both LTD and LTP arms tested\",\n      \"pmids\": [\"26482421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"5-HT7R physically interacts with CDK5, and constitutive (G-protein-independent) 5-HT7R activity is required for Tau hyperphosphorylation and formation of highly bundled Tau structures (HBTS) via CDK5; 5-HT7R-mediated CDK5 activation induces neuronal death, reduced LTP, and impaired memory in a Tau[R406W] mouse model; blockade of constitutive 5-HT7R activity prevented Tau hyperphosphorylation and neurotoxicity, and 5-HT7R knockdown in prefrontal cortex abrogated LTP deficits and memory impairments.\",\n      \"method\": \"Co-immunoprecipitation (5-HT7R–CDK5 interaction), Tau[R406W] overexpression mouse model, pharmacological blockade of constitutive 5-HT7R activity, 5-HT7R shRNA knockdown in prefrontal cortex, LTP recording, behavioral memory tests, CDK5 activity assays\",\n      \"journal\": \"Progress in neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein interaction (Co-IP), genetic knockdown, pharmacological blockade, electrophysiology (LTP), and behavior in same study; G-protein-independent mechanism established\",\n      \"pmids\": [\"32841723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"5-HT7R activation in the hippocampal CA1 region induces depressive-like behavior in an MMP-9-dependent manner: acute LP-211 (5-HT7R agonist) administration induced depressive-like behavior in mice, accompanied by dendritic spine elongation and decreased spine density; pharmacological modulation of 5-HT7R downstream effectors during chronic unpredictable stress similarly activated the 5-HT7R/MMP-9 pathway in CA1; post mortem human brain samples from depressed individuals revealed increased MMP-9 enzymatic activity in the hippocampus.\",\n      \"method\": \"5-HT7R agonist LP-211 in mice, MMP-9 inhibitor, behavioral tests, dendritic spine imaging, chronic unpredictable stress model, MMP-9 enzymatic activity assay in human post mortem hippocampal tissue\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (pharmacology, imaging, biochemistry, human tissue), mechanistic link between 5-HT7R and MMP-9 in CA1 established in both mouse and human tissue\",\n      \"pmids\": [\"35294881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT7R is coupled to Gα12 protein in addition to Gs, and Gα12-mediated signaling activates small GTPases of the Rho family, providing a second major signaling arm for 5-HT7R independent of cAMP.\",\n      \"method\": \"Intracellular signaling assays (review synthesis of primary data cited in this review paper; primary data from other labs)\",\n      \"journal\": \"Frontiers in behavioral neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — review paper summarizing established findings from primary literature; G12/Rho coupling mentioned as established but primary experimental methods not described within this abstract\",\n      \"pmids\": [\"25324743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-29a post-transcriptionally regulates 5-HT7R expression by binding its 3'UTR (confirmed by luciferase assay), downregulating 5-HT7R mRNA in hippocampal neurons; miR-29a overexpression impairs 5-HT7R-dependent neurite elongation and remodeling via inhibition of ERK signaling; in vivo, upregulation of miR-29a during hippocampal development parallels downregulation of 5-HT7R.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, miR-29a overexpression in hippocampal neurons, neurite morphometry, ERK pathway inhibition, in vivo developmental expression profiling\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct 3'UTR luciferase assay confirming miR-29a binding, functional rescue experiments, in vivo developmental validation; multiple orthogonal approaches\",\n      \"pmids\": [\"31292861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT7R activation increases expression and basal phosphorylation (at Tyr816) of full-length TrkB in cortical neurons, SH-SY5Y cells, and RGC-5 cells; the effect involves both Gαs and Gα12 downstream pathways depending on the cell system, and occurs within 30 min of receptor activation.\",\n      \"method\": \"Primary cerebral cortical cultures, SH-SY5Y and RGC-5 cell lines, selective 5-HT7R agonist LP-12, Western blot for TrkB expression and phospho-TrkB (Tyr816), pathway inhibitors for Gαs and Gα12\",\n      \"journal\": \"Frontiers in behavioral neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Western blot with pathway inhibitors across multiple cell systems; single lab, no reconstitution or structural validation\",\n      \"pmids\": [\"25426041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Methylphenidate administration to adolescent rats produced a marked increase in 5-HT7 (Htr7) receptor expression in the nucleus accumbens and increased synaptic contacts; a selective Htr7 antagonist fully counteracted MPH-reduced impulsive behavior and enhanced impulsivity when administered alone; 5-HT7 agonist-induced activation in striatal neuron primary cultures significantly increased neurite length, suggesting 5-HT7 mediates plastic remodeling of neuronal morphology.\",\n      \"method\": \"Adolescent rat MPH treatment, Htr7 expression analysis, behavioral impulsivity assay, selective Htr7 antagonist, striatal neuron primary culture with agonist, neurite length measurement\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological manipulation with in vitro neuronal morphology assay; behavioral and cellular phenotypes linked to 5-HT7 expression, single lab\",\n      \"pmids\": [\"19243449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The Drosophila ortholog of 5-HT7 (d5-HT7), expressed specifically in mushroom body (MB) neurons, is required for olfactory associative learning in larvae; d5-HT7 mediates learning via cAMP-dependent signaling; spatio-temporal restriction of d5-HT7 expression to the MB neurons was sufficient to rescue olfactory learning deficits in d5-HT7 null larvae.\",\n      \"method\": \"Drosophila d5-HT7 null mutants, tissue-specific rescue with MB-specific expression of d5-HT7, olfactory conditioning assay, cAMP-PKA pathway dissection\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic null and tissue-specific rescue establishes necessity and sufficiency; ortholog in Drosophila, cAMP mechanism consistent with mammalian 5-HT7\",\n      \"pmids\": [\"33277559\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HTR7 (5-HT7) is a seven-transmembrane Gs/G12-coupled GPCR that primarily signals through cAMP/PKA and, via EPAC-mTORC1, to regulate neuronal plasticity; it also activates Rho-family GTPases (Cdc42, RhoA) through Gα12 to drive cytoskeletal reorganization (neurite elongation, spine formation, synaptogenesis) mediated by CDK5, MAPK/ERK, and actin-binding proteins (cofilin); constitutive receptor activity (demonstrable as inverse agonism) contributes to spinogenesis and, via a G-protein-independent CDK5-dependent pathway, to Tau hyperphosphorylation; the receptor forms homodimers with highest affinity and 5-HT1A/5-HT7 heterodimers that attenuate 5-HT1A-Gi signaling and GIRK channel activity while enhancing MAPK activation; downstream effectors include TrkB (whose expression and phosphorylation are upregulated by 5-HT7R activation), MMP-9 (mediating depressive-like behavior in hippocampal CA1), and TRPA1 (mediating serotonergic itch peripherally); the receptor's cAMP signaling bifurcates into a PKA branch that constrains spinal respiratory plasticity and an EPAC-mTORC1 branch that drives phrenic motor facilitation; S100B interacts with 5-HT7R and negatively regulates its cAMP output in astrocytes; expression is post-transcriptionally suppressed by miR-29a via 3'UTR binding; the receptor mediates 5-HT-induced hypothermia, suppression of SCN photic responses, REM sleep regulation, inhibition of intestinal peristalsis via enteric neurons, anti-inflammatory macrophage polarization through myeloid CD11c cells, and both pronociceptive (peripheral, low-dose spinal) and antinociceptive (central sensitization context) pain modulation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HTR7 (5-HT7) is a serotonin-activated G-protein-coupled receptor that couples to Gs to stimulate adenylyl cyclase and cAMP production, governing neuronal plasticity, thermoregulation, circadian and sleep physiology, gut motility, immune polarization, nociception, and itch [#2, #3, #5]. The receptor exists as multiple C-terminal splice variants (h5-HT7a/b/d) that are all positively coupled to adenylyl cyclase, and it displays constitutive (agonist-independent) cAMP activity revealed by inverse agonists such as methiothepin [#2, #4]. Beyond classical Gs/cAMP signaling, 5-HT7R couples to G\\u03b112 to activate Rho-family GTPases, providing a parallel cytoskeletal signaling arm [#28]. Through these branches the receptor drives neurite/axonal elongation, dendritic spine formation, and synaptogenesis via downstream effectors including mTOR, CDK5, Cdc42, ERK, and the actin regulator cofilin [#21, #22]. The cAMP signal bifurcates functionally: a PKA branch that constrains spinal phrenic motor plasticity and an EPAC\\u2192mTORC1 branch that drives phrenic motor facilitation, the latter also requiring new TrkB synthesis and PI3K/AKT signaling [#13, #18, #24]. 5-HT7R activity upregulates TrkB expression and phosphorylation [#30], and its constitutive, G-protein-independent activity drives CDK5-dependent Tau hyperphosphorylation, neurotoxicity, and memory impairment [#26]. The receptor forms homodimers (highest affinity) and 5-HT1A/5-HT7 heterodimers that suppress 5-HT1A-Gi signaling and GIRK currents while enhancing MAPK activation [#15]. In the periphery and immune system it promotes M2 anti-inflammatory macrophage polarization, protects against intestinal inflammation via CD11c+ myeloid cells, and triggers serotonergic itch by opening TRPA1 [#16, #19, #23]. Receptor output is negatively modulated by direct binding of S100B, which dampens cAMP accumulation, and its expression is post-transcriptionally suppressed by miR-29a via 3'UTR binding [#20, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that 5-HT7 receptor signaling functionally modulates neuronal currents through the cAMP/PKA cascade, defining its core transduction mechanism in native neurons.\",\n      \"evidence\": \"Whole-cell voltage-clamp in rat SCN neurons with selective agonists/antagonists, forskolin, cAMP analogs, and PKA inhibitor\",\n      \"pmids\": [\"7965836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the receptor isoform or Gs subunit directly\", \"Restricted to GABAA current modulation in one nucleus\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that the receptor is encoded as multiple C-terminal splice variants all positively coupled to adenylyl cyclase, establishing Gs coupling at the molecular level and broad tissue expression.\",\n      \"evidence\": \"Molecular cloning and heterologous expression (NIH-3T3, HEK293) with radioligand binding and cAMP functional assays plus tissue mRNA analysis\",\n      \"pmids\": [\"9303561\", \"9298538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional differences between splice variants not resolved\", \"No structural information on the receptor\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identified 5-HT7 as the principal mediator of serotonergic suppression of SCN photic responses, linking receptor function to circadian physiology.\",\n      \"evidence\": \"Single-unit electrophysiology in hamster SCN slices with selective 5-HT7 vs 5-HT1A antagonists\",\n      \"pmids\": [\"9175892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling to clock machinery not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed that the receptor possesses constitutive (agonist-independent) adenylyl cyclase activity, expanding its mechanism to ligand-independent signaling demonstrable by inverse agonism.\",\n      \"evidence\": \"Adenylyl cyclase and inverse agonism profiling in transfected HEK293 membranes across all three splice variants\",\n      \"pmids\": [\"11906971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequences of constitutive activity not yet shown in this study\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Used genetic knockout to assign 5-HT-induced hypothermia and intestinal peristalsis inhibition to 5-HT7, establishing in vivo physiological roles and an allosteric lipid modulator (oleamide).\",\n      \"evidence\": \"5-HT7 knockout mice with thermoregulatory challenge; guinea-pig ileum peristalsis organ-bath assays with SB-269970\",\n      \"pmids\": [\"12529502\", \"12711620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway linking receptor to thermoregulation/motility not defined\", \"Oleamide mechanism remains independent of receptor\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Dissected the dose-dependent contributions of 5-HT7 versus 5-HT1A to hypothermia, showing 5-HT7 dominates at physiologically relevant agonist concentrations.\",\n      \"evidence\": \"Combined knockout and selective antagonist dose-response thermoregulation in mice\",\n      \"pmids\": [\"15033384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor circuitry mediating temperature drop not mapped\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected 5-HT7 to antidepressant-like behavior, REM sleep regulation, spinal nociceptive anatomy, and enteric peristalsis, broadening its behavioral and peripheral physiology.\",\n      \"evidence\": \"Knockout/antagonist behavioral and sleep EEG studies; spinal cord immunoEM localization; ileal peristalsis with confocal localization\",\n      \"pmids\": [\"16018977\", \"16082681\", \"16285955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signaling underlying behavioral phenotypes not established\", \"Spinal localization study lacked functional validation in same work\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Correlated 5-HT7 Gs/cAMP intrinsic efficacy with antinociception, directly tying the receptor's signaling output to a behavioral pain outcome.\",\n      \"evidence\": \"Parallel in vitro cAMP assays in HEK-293F (human receptor) and in vivo capsaicin hypersensitivity with selective agonists/antagonists\",\n      \"pmids\": [\"19118950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Site of antinociceptive action (central vs peripheral) not fully resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked 5-HT7 to hippocampus-dependent spatial memory and to plastic neuronal remodeling, while excluding adult neurogenesis as the mechanism.\",\n      \"evidence\": \"Knockout/antagonist behavioral paradigms with BrdU; adolescent rat methylphenidate study with striatal neurite assays\",\n      \"pmids\": [\"19447277\", \"19243449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signaling for memory role not defined\", \"Methylphenidate-receptor link is correlative in vivo\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined opposing spinal cAMP branches and synaptic circuit actions, showing 5-HT7-driven phrenic motor facilitation requires TrkB/PI3K and that it modulates hippocampal inhibitory transmission.\",\n      \"evidence\": \"Intrathecal pharmacology with TrkB siRNA/k252a/PI3K inhibitors and phrenic electrophysiology; whole-cell patch-clamp in rat hippocampal slices\",\n      \"pmids\": [\"21242254\", \"22204801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of new TrkB independent of BDNF unexplained\", \"Presynaptic vs postsynaptic receptor populations not genetically resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established that 5-HT7 forms homodimers and 5-HT1A/5-HT7 heterodimers that reshape signaling, suppressing 5-HT1A-Gi/GIRK output while enhancing MAPK.\",\n      \"evidence\": \"FRET dimerization affinity, Gi functional/GIRK recordings, internalization and MAPK assays in heterologous cells and hippocampal neurons\",\n      \"pmids\": [\"22357950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dimer interface unknown\", \"In vivo behavioral consequences of heterodimerization not tested here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended 5-HT7 function to immune and hepatic biology, mediating M2 macrophage polarization and cAMP/PKA-CREB/AKT-driven IGF-1 secretion in hepatocytes.\",\n      \"evidence\": \"Human macrophage polarization with selective antagonists; isolated rat hepatocyte biochemistry with antagonist reversal\",\n      \"pmids\": [\"23355731\", \"23578138\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor-proximal signaling in macrophages not detailed\", \"Single-lab studies without genetic confirmation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a second signaling arm (G\\u03b112/Rho), an S100B negative regulator, and TrkB upregulation, diversifying the receptor's effector landscape beyond cAMP.\",\n      \"evidence\": \"Review synthesis of G12/Rho coupling; Co-IP and cAMP assays for S100B in HeLa and astrocytes with transgenic mice; Western blots of TrkB/phospho-TrkB across cell lines with Gs/G12 inhibitors\",\n      \"pmids\": [\"25324743\", \"26499172\", \"25426041\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"G12/Rho coupling cited from review, primary methods not detailed\", \"S100B interaction structure unknown\", \"TrkB phosphorylation mechanism not fully mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mechanistically resolved 5-HT7-driven structural plasticity (spinogenesis, neurite/axon elongation) through CDK5/Cdc42/mTOR/ERK and cofilin, and separated the spinal cAMP signal into PKA-constraining and EPAC-mTORC1-facilitating branches; also established cerebellar plasticity, itch via TRPA1, and intestinal anti-inflammatory roles.\",\n      \"evidence\": \"Knockout/agonist neuron cultures with effector inhibitors and microfluidic axon assays; intrathecal EPAC/PKA/mTORC1 pharmacology and phrenic electrophysiology; cerebellar slice electrophysiology; HTR7/TRPA1 double knockout itch models; DSS colitis with bone marrow chimera\",\n      \"pmids\": [\"28122114\", \"25814944\", \"26269554\", \"26482421\", \"26074006\", \"25072499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cAMP selectively routes to PKA vs EPAC not defined\", \"Direct receptor-TRPA1 coupling mechanism unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established miR-29a as a post-transcriptional brake on receptor expression that limits 5-HT7-dependent neurite remodeling via ERK during hippocampal development.\",\n      \"evidence\": \"Luciferase 3'UTR reporter, miR-29a overexpression with neurite morphometry and ERK inhibition, in vivo developmental expression profiling\",\n      \"pmids\": [\"31292861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream regulators of miR-29a not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that constitutive, G-protein-independent 5-HT7 activity physically engages CDK5 to drive Tau hyperphosphorylation and neurotoxicity, and confirmed conserved cAMP-dependent learning function via the Drosophila ortholog.\",\n      \"evidence\": \"Co-IP, Tau[R406W] mouse model, constitutive-activity blockade, prefrontal shRNA knockdown with LTP and memory tests; Drosophila d5-HT7 null and MB-specific rescue olfactory conditioning\",\n      \"pmids\": [\"32841723\", \"33277559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of G-protein-independent CDK5 coupling unknown\", \"Relevance to human tauopathy not directly tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked 5-HT7 activation in hippocampal CA1 to depressive-like behavior through an MMP-9-dependent pathway, with corroborating elevated MMP-9 in human depressed hippocampus.\",\n      \"evidence\": \"LP-211 agonist with MMP-9 inhibitor, behavioral tests, dendritic spine imaging, chronic stress model, and human post-mortem MMP-9 activity assays\",\n      \"pmids\": [\"35294881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling steps connecting receptor to MMP-9 induction not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the receptor's cAMP output is selectively partitioned between PKA and EPAC branches, and the structural determinants of its G-protein-independent CDK5 coupling and dimerization, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the receptor or its dimer/effector interfaces\", \"Mechanism of branch selection between PKA and EPAC unknown\", \"No direct disease-causing mutation established in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 3, 11]},\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": [2, 3, 4, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 11, 24, 28]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [14, 21, 22, 25]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 19]}\n    ],\n    \"complexes\": [\"5-HT1A/5-HT7 heterodimer\", \"5-HT7 homodimer\"],\n    \"partners\": [\"HTR1A\", \"S100B\", \"CDK5\", \"TrkB\", \"TRPA1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}